These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28844343)

  • 1. Inclusion of elderly or frail patients in randomized controlled trials of targeted therapies for the treatment of metastatic colorectal cancer: A systematic review.
    Gouverneur A; Salvo F; Berdaï D; Moore N; Fourrier-Réglat A; Noize P
    J Geriatr Oncol; 2018 Jan; 9(1):15-23. PubMed ID: 28844343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Safety of Targeted Therapies for Metastatic Colorectal Cancer between Elderly and Younger Patients: a Study Using the International Pharmacovigilance Database.
    Gouverneur A; Claraz P; Rousset M; Arnaud M; Fourrier-Réglat A; Pariente A; Aparicio T; Miremont-Salamé G; Noize P
    Target Oncol; 2017 Dec; 12(6):805-814. PubMed ID: 29022151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical effectiveness and cost-effectiveness of cetuximab (review of technology appraisal no. 176) and panitumumab (partial review of technology appraisal no. 240) for previously untreated metastatic colorectal cancer: a systematic review and economic evaluation.
    Huxley N; Crathorne L; Varley-Campbell J; Tikhonova I; Snowsill T; Briscoe S; Peters J; Bond M; Napier M; Hoyle M
    Health Technol Assess; 2017 Jun; 21(38):1-294. PubMed ID: 28682222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of Use, Safety, and Effectiveness of Targeted Therapies in First-Line Treatment of Metastatic Colorectal Cancer According to Age: The STROMBOLI Cohort Study.
    Gouverneur A; Coutureau J; Jové J; Rouyer M; Grelaud A; Duc S; Gérard S; Smith D; Ravaud A; Droz C; Bernard MA; Lassalle R; Forrier-Réglat A; Noize P;
    Clin Colorectal Cancer; 2019 Mar; 18(1):e150-e162. PubMed ID: 30630730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-Agent Panitumumab in Frail Elderly Patients With Advanced RAS and BRAF Wild-Type Colorectal Cancer: Challenging Drug Label to Light Up New Hope.
    Pietrantonio F; Cremolini C; Aprile G; Lonardi S; Orlandi A; Mennitto A; Berenato R; Antoniotti C; Casagrande M; Marsico V; Marmorino F; Cardellino GG; Bergamo F; Tomasello G; Formica V; Longarini R; Giommoni E; Caporale M; Di Bartolomeo M; Loupakis F; de Braud F
    Oncologist; 2015 Nov; 20(11):1261-5. PubMed ID: 26446234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cetuximab: clinical results in colorectal cancer.
    Maiello E; Giuliani F; Gebbia V; Piano A; Agueli R; Colucci G
    Ann Oncol; 2007 Jun; 18 Suppl 6():vi8-10. PubMed ID: 17591840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of molecular targeted agents in the treatment of elderly patients with metastatic colorectal cancer: Does the age matter?
    Zhao CJ; Li S; Liu Q
    J Cancer Res Ther; 2018; 14(Supplement):S79-S84. PubMed ID: 29578154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies in the treatment of metastatic colorectal cancer: a review.
    Tol J; Punt CJ
    Clin Ther; 2010 Mar; 32(3):437-53. PubMed ID: 20399983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-line single-agent panitumumab in frail elderly patients with wild-type KRAS metastatic colorectal cancer and poor prognostic factors: A phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours.
    Sastre J; Massuti B; Pulido G; Guillén-Ponce C; Benavides M; Manzano JL; Reboredo M; Rivera F; Grávalos C; Safont MJ; Martínez Villacampa M; Llovet P; Dotor E; Díaz-Rubio E; Aranda E;
    Eur J Cancer; 2015 Jul; 51(11):1371-80. PubMed ID: 25963019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of RAS mutations and individual variation patterns among patients with metastatic colorectal cancer: A pooled analysis of randomised controlled trials.
    Peeters M; Kafatos G; Taylor A; Gastanaga VM; Oliner KS; Hechmati G; Terwey JH; van Krieken JH
    Eur J Cancer; 2015 Sep; 51(13):1704-13. PubMed ID: 26049686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bevacizumab treatment in the elderly patient with metastatic colorectal cancer.
    Di Bartolomeo M; Maggi C; Ricchini F; Pietrantonio F; Iacovelli R; de Braud F; Inno A
    Clin Interv Aging; 2015; 10():127-33. PubMed ID: 25584021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review and assessment of currently available data of the EGFR antibodies in elderly patients with metastatic colorectal cancer.
    Rosati G; Aprile G; Cardellino GG; Avallone A
    J Geriatr Oncol; 2016 Mar; 7(2):134-41. PubMed ID: 26897044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging VEGF-receptor inhibitors for colorectal cancer.
    Martinelli E; Troiani T; Morgillo F; Orditura M; De Vita F; Belli G; Ciardiello F
    Expert Opin Emerg Drugs; 2013 Mar; 18(1):25-37. PubMed ID: 23216053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eligibility of real-world patients with chemo-refractory, K-RAS wild-type, metastatic colorectal cancer for palliative intent regorafenib monotherapy.
    Angeles A; Hung W; Cheung WY
    Med Oncol; 2018 Jun; 35(8):114. PubMed ID: 29936654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant increase of synchronous disease in first-line metastatic colorectal cancer trials: Results of a systematic review.
    Goey KK; 't Lam-Boer J; de Wilt JH; Punt CJ; van Oijen MG; Koopman M
    Eur J Cancer; 2016 Dec; 69():166-177. PubMed ID: 27821320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of molecular targetted agents in the treatment of elderly patients with metastatic colorectal cancer: does the age matter?
    Zhao C; Li S; Liu Q
    J Chemother; 2016 Aug; 28(4):321-7. PubMed ID: 26239366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing underrepresentation of elderly patients with advanced colorectal or non-small-cell lung cancer in chemotherapy trials.
    Jennens RR; Giles GG; Fox RM
    Intern Med J; 2006 Apr; 36(4):216-20. PubMed ID: 16640737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Modalities and Survival in Older Adults with Metastatic Colorectal Cancer in Real Life.
    Gouverneur A; Bezin J; Jové J; Bosco-Lévy P; Fourrier-Réglat A; Noize P
    J Am Geriatr Soc; 2019 May; 67(5):913-919. PubMed ID: 30840323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Panitumumab Provides Better Survival Outcomes Compared to Cetuximab for Metastatic Colorectal Cancer Patients Treated with Prior Bevacizumab within 6 Months.
    Hayashi K; Mitani S; Taniguchi H; Yasui H; Muro K; Mori K; Gotoda T; Yamazaki K
    Oncology; 2019; 96(3):132-139. PubMed ID: 30359979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted Therapies in Elderly Patients with Metastatic Colorectal Cancer: A Review of the Evidence.
    Tapia Rico G; Townsend AR; Broadbridge V; Price TJ
    Drugs Aging; 2017 Mar; 34(3):173-189. PubMed ID: 28197947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.